Cargando…

Serum anti-modified citrullinated vimentin antibody concentration is associated with liver fibrosis in patients with chronic hepatitis

BACKGROUND AND AIMS: The hepatic stellate cell, which plays a pivotal role in hepatic fibrosis, contains the filament vimentin which is known to undergo protein citrullination and become immunogenic. The aims of this study were to find out if anti-modified citrullinated vimentin (anti-MCV) antibodie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abdeen, Suad, Olusi, Samuel O, George, Sunila
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2011
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3846543/ https://www.ncbi.nlm.nih.gov/pubmed/24367216 http://dx.doi.org/10.2147/HMER.S17039

Ejemplares similares

Characterization of patients with anti-modified citrullinated vimentin antibodies (MCVA)
por: Ruiz-Ortiz de Arrizabaleta, Estíbaliz, et al.
Publicado: (2011)

Evaluation of anti-citrullinated type II collagen and anti-citrullinated vimentin antibodies in patients with juvenile idiopathic arthritis
por: Gilliam, Brooke E, et al.
Publicado: (2013)

Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin
por: Vossenaar, Erik R, et al.
Publicado: (2004)

Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis
por: Dejaco, Christian, et al.
Publicado: (2006)

Evaluation of Anti-Mutated Citrullinated Vimentin Antibodies, Anti-Cyclic Citrullinated Peptide Antibodies and Rheumatoid Factor in Omani Patients with Rheumatoid Arthritis
por: Al-Shukaili, Ahmed, et al.
Publicado: (2012)

The Relationship of Antibodies to Modified Citrullinated Vimentin and Markers of Bone and Cartilage Destruction in Rheumatoid Arthritis
por: Avdeeva, A. S., et al.
Publicado: (2014)

The relevance of citrullinated vimentin in the production of antibodies against citrullinated proteins and the pathogenesis of rheumatoid arthritis
por: Van Steendam, Katleen, et al.
Publicado: (2011)

Pattern of drugs use and association with anti-mutated citrullinated vimentin antibody in rheumatoid arthritis
por: Safi, Mohammad-Ayman A., et al.
Publicado: (2015)

Anti-modified citrullinated vimentin antibody: a novel biomarker associated with cardiac systolic dysfunction in patients with rheumatoid arthritis
por: Norouzi, Somayye, et al.
Publicado: (2020)

Comparison of Two Assays to Determine Anti-Citrullinated Peptide Antibodies in Rheumatoid Arthritis in relation to Other Chronic Inflammatory Rheumatic Diseases: Assaying Anti-Modified Citrullinated Vimentin Antibodies Adds Value to Second-Generation Anti-Citrullinated Cyclic Peptides Testing
por: Díaz-Toscano, Miriam Lizette, et al.
Publicado: (2014)

Diagnostic value and clinical significance of antibodies against a modified citrullinated vimentin (anti-MCV) in patients with early juvenile arthritis
por: Salugina, SO, et al.
Publicado: (2008)

The value of antibodies against mutated citrullinated vimentin in juvenile idiopathic arthritis
por: Guseinova, D, et al.
Publicado: (2008)

Effects of rituximab treatment on the serum concentrations of vitamin D and interleukins 2, 6, 7, and 10 in patients with rheumatoid arthritis
por: Hasan, Eman, et al.
Publicado: (2012)

Anti-Cyclic Citrullinated Peptide (Anti-CCP) and Anti-Mutated Citrullinated Vimentin (Anti-MCV) Relation with Extra-Articular Manifestations in Rheumatoid Arthritis
por: Gonzalez-Lopez, Laura, et al.
Publicado: (2014)

Vimentin and Anti Vimentin Antibodies in Chagas' Disease
por: Nascimento, Marilda Savoia, et al.
Publicado: (2018)

Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy
por: Nicaise Roland, Pascale, et al.
Publicado: (2008)

The rheumatoid arthritis specific Sa antigen is citrullinated vimentin
por: Vossenaar, ER, et al.
Publicado: (2004)

Citrullinated vimentin as an important antigen in immune complexes from synovial fluid of rheumatoid arthritis patients with antibodies against citrullinated proteins
por: Van Steendam, Katleen, et al.
Publicado: (2010)

Antibodies to mutated citrullinated vimentin and disease activity score in early arthritis: a cohort study
por: Ursum, Jennie, et al.
Publicado: (2008)

Prevalence of LDL atherogenic phenotype in patients with systemic lupus erythematosus
por: Olusi, Samuel O, et al.
Publicado: (2011)

Antibodies to Mutated Citrullinated Vimentin in Rheumatoid Arthritis: Diagnostic Value, Association with Radiological Damage and Axial Skeleton Affection
por: Mansour, Howaida E., et al.
Publicado: (2010)

Restrictive IgG antibody response against mutated citrullinated vimentin predicts response to rituximab in patients with rheumatoid arthritis
por: Lindenberg, Luisa, et al.
Publicado: (2015)

Role of anti-vimentin antibodies in allograft rejection
por: Rose, Marlene L
Publicado: (2013)

An anti vimentin antibody promotes tube formation
por: Jørgensen, Mathias Lindh, et al.
Publicado: (2017)

Detection of Anti-Vimentin Antibodies in Patients with Sarcoidosis
por: Starshinova, Anna, et al.
Publicado: (2022)

Anti-mutated citrulline vimentin antibodies may be higher in Ankylosing spondylitis, but may not have a role in diagnosing disease and may not be associated with disease severity
por: Sen, Nesrin, et al.
Publicado: (2023)

Combination vaccine based on citrullinated vimentin and enolase peptides induces potent CD4-mediated anti-tumor responses
por: Brentville, Victoria A, et al.
Publicado: (2020)

In Contrast to Anti-CCP, MMP-Degraded and Citrullinated Vimentin (VICM) Is Both a Diagnostic and a Treatment Response Biomarker
por: Drobinski, Patryk J., et al.
Publicado: (2022)

Characterization of Monoclonal Antibodies Recognizing Citrulline-Modified Residues
por: Chen, Yaqiong, et al.
Publicado: (2022)

Epitope Specificity of Anti-Citrullinated Protein Antibodies
por: Trier, Nicole H., et al.
Publicado: (2017)

Anti-citrullinated protein antibody specificities and pulmonary fibrosis in relation to genetic loci in early rheumatoid arthritis
por: Brink, Mikael, et al.
Publicado: (2022)

Specificity of Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis
por: Trier, Nicole H., et al.
Publicado: (2019)

Secretory anti-citrullinated protein antibodies in serum associate with lung involvement in early rheumatoid arthritis
por: Roos Ljungberg, Karin, et al.
Publicado: (2020)

Pathogenic Role of Circulating Citrullinated Antigens and Anti-Cyclic Monoclonal Citrullinated Peptide Antibodies in Rheumatoid Arthritis
por: Won, Pureun, et al.
Publicado: (2021)

Specificity of Anti-Citrullinated Protein Antibodies to Citrullinated α-Enolase Peptides as a Function of Epitope Structure and Composition
por: Fanelli, Ilaria, et al.
Publicado: (2021)

Contribution of Peptide Backbone to Anti-Citrullinated Peptide Antibody Reactivity
por: Trier, Nicole Hartwig, et al.
Publicado: (2015)

The roles of anti-citrullinated protein antibodies in the immunopathogenesis of rheumatoid arthritis
por: Yu, Hui-Chun, et al.
Publicado: (2019)

Higher Levels of Autoantibodies Targeting Mutated Citrullinated Vimentin in Patients with Psoriatic Arthritis Than in Patients with Psoriasis Vulgaris
por: Dalmády, Szandra, et al.
Publicado: (2013)

Extracellular Release of Citrullinated Vimentin Directly Acts on Osteoclasts to Promote Bone Resorption in a Mouse Model of Periodontitis
por: Shindo, Satoru, et al.
Publicado: (2023)

Precise epitope determination of the anti-vimentin monoclonal antibody V9
por: Tomiyama, Lucia, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_r51lja2jie9tlodlbt1nufh1rv